VEGZELMA

PeakADC

bevacizumab-adcd

Celltrion
BLAINJECTIONINJECTABLE
Approved
Sep 2022
Lifecycle
Peak
Competitive Pressure
30/100

Mechanism of Action

Vascular Endothelial Growth Factor-directed Antibody Interactions

Pharmacologic Class:

Vascular Endothelial Growth Factor Inhibitor

Company
Celltrion
Celltrion
Korea - Incheon
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers